Deciphera Announces Health Canada’s Authorization of QINLOCK™ (ripretinib) for the Treatment of 4L Gastrointestinal Stromal Tumor

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced that Health Canada has authorized QINLOCK™ (ripretinib), a switch-control tyrosine kinase inhibitor, for sale in Canada for the treatment of adult patients with advanced gastrointestinal stromal tumor (GIST) who have received prior treatment with imatinib, sunitinib, and regorafenib.

By |2020-06-22T09:47:31-04:00June 22nd, 2020|Drug Treatment, News, Qinlock|

QINLOCK (ripretinib) – aprobado como cuarta línea de tratamiento para GIST

La FDA aprobó QINLOCKTM (ripretinib) para el tratamiento de adultos con tumor avanzado del estroma gastrointestinal (GIST) que han recibido 3 o más tratamientos previos para su GIST.

By |2020-06-17T11:29:18-04:00June 17th, 2020|Drug Treatment, Global, News, Qinlock|

¿Eres paciente con GIST de habla hispana? (Reunión Virtual)

¿Eres paciente con GIST de habla hispana? Por favor únase a nosotros para esta Reunión Virtual. Aprendiendo más sobre GIST y las nuevas terapias aprobadas. Jueves 11 de junio a las 1900 hrs tiempo Ciudad de México. Presentado por Dr. David Heredia, Oncólogo médico Instituto Nacional de Cancerología.

By |2020-06-10T09:39:36-04:00June 9th, 2020|, , |

Salud con Datos Produces Unique Analysis of Chilean & Mexican Patient Registries

This study is the result of a collaborative effort between Chile and Mexico, called Salud con Datos that sought to determine GIST prevalence, patients’ clinical characteristics and survival rates. Our report is the largest of its kind in Latin America.

By |2020-05-07T11:33:29-04:00May 7th, 2020|Global, News, Patient Registry|

How to Balance Your Diet During the COVID-19 Pandemic

Nutritional status plays a very important role in the prevention and treatment of contagious and non-contagious diseases. In the frame of a health contingency, the use of strategies that strengthen our nutritional status and immune system is essential.

By |2020-04-03T11:49:23-04:00April 1st, 2020|News, Nutrition, Patient Support|
Go to Top